Align Technology Launches Swiss Oral Health Study
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 25 2024
0mins
Should l Buy ALGN?
Source: Business Insider
Align Technology's stock rose by 5.04% as it reached a 20-day high amid positive market conditions.
The company announced a collaboration with the University of Bern to launch Switzerland's first oral health study, aiming to assess approximately 1,800 children and 1,650 adults by 2027. This initiative will utilize the iTero Lumina scanner for enhanced diagnostic capabilities, showcasing Align's commitment to improving public health through innovative technology.
This collaboration not only strengthens Align's market position but also highlights the potential for significant advancements in oral health diagnostics, which could lead to increased demand for its products.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ALGN?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ALGN
Wall Street analysts forecast ALGN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ALGN is 176.70 USD with a low forecast of 150.00 USD and a high forecast of 205.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
12 Analyst Rating
7 Buy
4 Hold
1 Sell
Moderate Buy
Current: 175.620
Low
150.00
Averages
176.70
High
205.00
Current: 175.620
Low
150.00
Averages
176.70
High
205.00
About ALGN
Align Technology, Inc. is a global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad computer-aided design and computer-aided manufacturing (CAD/CAM) software for digital orthodontics and restorative dentistry. The Company provides Align Digital Platform. Its segments include Clear Aligner, and Imaging Systems and CAD/CAM Services (Systems and Services). The Clear Aligner segment consists of comprehensive products, non-comprehensive products and non-case products. Its comprehensive products include Invisalign Comprehensive and Invisalign First. The Company's non-case products include retention products, Invisalign training and adjusting tools. It offers up to four sets of custom clear aligners called Vivera retainers. The Systems and Services segment consists of its iTero intraoral scanning systems. Its services include subscription software, disposables, rentals, leases and pay per scan services.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
US Stocks Plunge as Tech Sector Leads Decline
- Tech Sector Decline: Qualcomm's (QCOM) forecast of weaker-than-expected Q2 revenue led to an over 8% drop in its stock, triggering a sell-off across the tech sector, with the Nasdaq 100 index hitting a 2.5-month low, indicating waning investor confidence in technology stocks.
- Weak Labor Market Signals: Challenger's report revealed a staggering 117.8% year-over-year increase in job cuts for January, totaling 108,435, the highest for January since 2009, while initial jobless claims rose by 22,000 to 231,000, highlighting vulnerabilities in the US labor market that could hinder economic recovery.
- Bitcoin Plunge: Bitcoin (^BTCUSD) plummeted over 12% to a 1.25-year low, reflecting deepening negative momentum in the cryptocurrency market, with approximately $2 billion flowing out of Bitcoin ETFs in the past month, signaling a decline in investor confidence.
- Earnings Season Impact: Despite 150 S&P 500 companies set to report earnings this week, market focus on economic data intensifies, with S&P 500 earnings expected to grow by 8.4% in Q4, yet overall market sentiment remains suppressed by recent economic weakness.
See More
US Stocks Plunge Sharply, Led by Technology Sector Declines
- Technology Sector Decline: Qualcomm (QCOM) forecasts Q2 revenue between $10.2 billion and $11.0 billion, below the consensus of $11.18 billion, leading to an over 8% drop in its stock and exacerbating the overall decline in the Nasdaq 100 index, heightening market panic.
- Weak Labor Market Signals: Challenger's report shows January job cuts surged 117.8% year-on-year to 108,435, marking the highest level since 2009, indicating fragility in the US labor market and increasing investor concerns about economic outlook.
- Bitcoin Price Crash: Bitcoin (^BTCUSD) is down more than 7% today, hitting a 1.25-year low and falling about 45% from its October record high, reflecting negative sentiment in the cryptocurrency market and a trend of capital outflows.
- Impact of Earnings Season: Despite 150 S&P 500 companies set to report earnings this week and 81% of the 237 companies that have reported exceeding expectations, market concerns over future economic data continue to suppress stock performance, with S&P earnings growth expected to reach 8.4% in Q4.
See More
Significant Stock Movements in Midday Trading
- McKesson Earnings Beat: McKesson's fiscal third-quarter earnings per share exceeded Wall Street's highest estimates, and the adjusted full-year EPS guidance was raised above analyst consensus, leading to a 16% stock price increase, indicating strong performance in the medical supply sector.
- Bob's Discount Furniture IPO: Bob's Discount Furniture debuted on the New York Stock Exchange with shares priced at $17, recently rising 10%, marking a successful entry into the public market and laying the groundwork for future growth.
- Fluence Energy Earnings Miss: Fluence Energy reported first-quarter revenue of $475.2 million, falling short of the $481.2 million consensus, with a per-share loss of 34 cents missing the 21-cent loss estimate, resulting in a 31% stock price drop, reflecting market concerns over its profitability.
- Cardinal Health Guidance Raised: Cardinal Health reported quarterly adjusted earnings of $2.63 per share, exceeding the $2.36 consensus, with revenue of $65.63 billion surpassing the $64.14 billion estimate, leading to an 8% stock price increase, showcasing strong growth potential in the healthcare services sector.
See More
U.S. Stocks Extend Losses, Led by Technology Sector Declines
- Technology Sector Decline: Qualcomm (QCOM) forecasts Q2 revenue between $10.2 billion and $11.0 billion, below the consensus of $11.18 billion, leading to a more than 9% drop in its stock and triggering a sell-off across the chip sector, exacerbating market anxiety.
- Weak Labor Market Signals: Challenger reports a staggering 117.8% year-over-year increase in job cuts for January, totaling 108,435, the highest since 2009, while initial jobless claims rose by 22,000 to 231,000, indicating a weakening labor market that could impact consumer confidence and spending.
- Fed Policy Implications: Fed Governor Lisa Cook supports the decision to hold interest rates steady, emphasizing the need to maintain credibility after nearly five years of above-target inflation, which may influence future monetary policy directions.
- Bitcoin Market Turmoil: Bitcoin (^BTCUSD) is down over 3% today, hitting a 1.25-year low and falling approximately 45% from its October record high, with about $5 billion pulled from Bitcoin ETFs over the past three months, reflecting waning market confidence in cryptocurrencies.
See More
Align Technology Reports Strong Q4 Earnings Beat
- Revenue Growth: Align Technology reported a 5.3% year-over-year increase in Q4 revenues to $1.048 billion, surpassing the consensus estimate of $1.033 billion, with foreign exchange contributing approximately $14.8 million, indicating strong performance in global markets.
- Adjusted EPS: The company posted an adjusted EPS of $3.29, exceeding the consensus of $2.97, reflecting improved profitability and effective cost management strategies.
- Future Guidance: For Q1, Align expects revenues between $1.010 billion and $1.030 billion, representing a year-over-year growth of 3% to 5%, slightly below the consensus of $1.022 billion, indicating a cautious outlook for future growth.
- Stock Price Reaction: Align Technology's shares rose by 10.7% to $178.53 on Thursday, reflecting a positive market reaction to its earnings and an increase in investor confidence.
See More
Significant Premarket Trading Moves by Multiple Companies
- Qualcomm's Downgraded Forecast: Qualcomm's stock plummeted nearly 11% as the company projected adjusted earnings of $2.45 to $2.65 per share and revenue of $10.2 to $11 billion for Q2, both below analyst expectations of $11.11 billion and $2.89 per share, reflecting concerns over a global memory shortage.
- Estee Lauder's Disappointing Results: Despite reporting adjusted earnings of $0.89 per share, exceeding the $0.84 expected by analysts, Estee Lauder's stock fell 12%, indicating market skepticism about future growth, even as the company raised its full-year earnings guidance to $2.05 to $2.25 per share.
- Align Technology's Strong Performance: Align Technology's stock rose 2.7% after reporting fourth-quarter earnings of $3.29 per share, surpassing the $2.97 consensus estimate, with revenue of $1.05 billion exceeding expectations of $1.03 billion, showcasing robust demand for its products.
- Bristol-Myers Squibb's Stock Increase: The pharmaceutical giant's stock gained 2% after posting fourth-quarter adjusted earnings of $1.26 per share and revenues of $12.5 billion, both exceeding analyst expectations, highlighting its competitive strength and growth potential in the market.
See More
US Stocks Plunge as Tech Sector Leads Decline
- Tech Sector Decline: Qualcomm's (QCOM) forecast of weaker-than-expected Q2 revenue led to an over 8% drop in its stock, triggering a sell-off across the tech sector, with the Nasdaq 100 index hitting a 2.5-month low, indicating waning investor confidence in technology stocks.
- Weak Labor Market Signals: Challenger's report revealed a staggering 117.8% year-over-year increase in job cuts for January, totaling 108,435, the highest for January since 2009, while initial jobless claims rose by 22,000 to 231,000, highlighting vulnerabilities in the US labor market that could hinder economic recovery.
- Bitcoin Plunge: Bitcoin (^BTCUSD) plummeted over 12% to a 1.25-year low, reflecting deepening negative momentum in the cryptocurrency market, with approximately $2 billion flowing out of Bitcoin ETFs in the past month, signaling a decline in investor confidence.
- Earnings Season Impact: Despite 150 S&P 500 companies set to report earnings this week, market focus on economic data intensifies, with S&P 500 earnings expected to grow by 8.4% in Q4, yet overall market sentiment remains suppressed by recent economic weakness.
See More
US Stocks Plunge Sharply, Led by Technology Sector Declines
- Technology Sector Decline: Qualcomm (QCOM) forecasts Q2 revenue between $10.2 billion and $11.0 billion, below the consensus of $11.18 billion, leading to an over 8% drop in its stock and exacerbating the overall decline in the Nasdaq 100 index, heightening market panic.
- Weak Labor Market Signals: Challenger's report shows January job cuts surged 117.8% year-on-year to 108,435, marking the highest level since 2009, indicating fragility in the US labor market and increasing investor concerns about economic outlook.
- Bitcoin Price Crash: Bitcoin (^BTCUSD) is down more than 7% today, hitting a 1.25-year low and falling about 45% from its October record high, reflecting negative sentiment in the cryptocurrency market and a trend of capital outflows.
- Impact of Earnings Season: Despite 150 S&P 500 companies set to report earnings this week and 81% of the 237 companies that have reported exceeding expectations, market concerns over future economic data continue to suppress stock performance, with S&P earnings growth expected to reach 8.4% in Q4.
See More
Significant Stock Movements in Midday Trading
- McKesson Earnings Beat: McKesson's fiscal third-quarter earnings per share exceeded Wall Street's highest estimates, and the adjusted full-year EPS guidance was raised above analyst consensus, leading to a 16% stock price increase, indicating strong performance in the medical supply sector.
- Bob's Discount Furniture IPO: Bob's Discount Furniture debuted on the New York Stock Exchange with shares priced at $17, recently rising 10%, marking a successful entry into the public market and laying the groundwork for future growth.
- Fluence Energy Earnings Miss: Fluence Energy reported first-quarter revenue of $475.2 million, falling short of the $481.2 million consensus, with a per-share loss of 34 cents missing the 21-cent loss estimate, resulting in a 31% stock price drop, reflecting market concerns over its profitability.
- Cardinal Health Guidance Raised: Cardinal Health reported quarterly adjusted earnings of $2.63 per share, exceeding the $2.36 consensus, with revenue of $65.63 billion surpassing the $64.14 billion estimate, leading to an 8% stock price increase, showcasing strong growth potential in the healthcare services sector.
See More
U.S. Stocks Extend Losses, Led by Technology Sector Declines
- Technology Sector Decline: Qualcomm (QCOM) forecasts Q2 revenue between $10.2 billion and $11.0 billion, below the consensus of $11.18 billion, leading to a more than 9% drop in its stock and triggering a sell-off across the chip sector, exacerbating market anxiety.
- Weak Labor Market Signals: Challenger reports a staggering 117.8% year-over-year increase in job cuts for January, totaling 108,435, the highest since 2009, while initial jobless claims rose by 22,000 to 231,000, indicating a weakening labor market that could impact consumer confidence and spending.
- Fed Policy Implications: Fed Governor Lisa Cook supports the decision to hold interest rates steady, emphasizing the need to maintain credibility after nearly five years of above-target inflation, which may influence future monetary policy directions.
- Bitcoin Market Turmoil: Bitcoin (^BTCUSD) is down over 3% today, hitting a 1.25-year low and falling approximately 45% from its October record high, with about $5 billion pulled from Bitcoin ETFs over the past three months, reflecting waning market confidence in cryptocurrencies.
See More
Align Technology Reports Strong Q4 Earnings Beat
- Revenue Growth: Align Technology reported a 5.3% year-over-year increase in Q4 revenues to $1.048 billion, surpassing the consensus estimate of $1.033 billion, with foreign exchange contributing approximately $14.8 million, indicating strong performance in global markets.
- Adjusted EPS: The company posted an adjusted EPS of $3.29, exceeding the consensus of $2.97, reflecting improved profitability and effective cost management strategies.
- Future Guidance: For Q1, Align expects revenues between $1.010 billion and $1.030 billion, representing a year-over-year growth of 3% to 5%, slightly below the consensus of $1.022 billion, indicating a cautious outlook for future growth.
- Stock Price Reaction: Align Technology's shares rose by 10.7% to $178.53 on Thursday, reflecting a positive market reaction to its earnings and an increase in investor confidence.
See More
Significant Premarket Trading Moves by Multiple Companies
- Qualcomm's Downgraded Forecast: Qualcomm's stock plummeted nearly 11% as the company projected adjusted earnings of $2.45 to $2.65 per share and revenue of $10.2 to $11 billion for Q2, both below analyst expectations of $11.11 billion and $2.89 per share, reflecting concerns over a global memory shortage.
- Estee Lauder's Disappointing Results: Despite reporting adjusted earnings of $0.89 per share, exceeding the $0.84 expected by analysts, Estee Lauder's stock fell 12%, indicating market skepticism about future growth, even as the company raised its full-year earnings guidance to $2.05 to $2.25 per share.
- Align Technology's Strong Performance: Align Technology's stock rose 2.7% after reporting fourth-quarter earnings of $3.29 per share, surpassing the $2.97 consensus estimate, with revenue of $1.05 billion exceeding expectations of $1.03 billion, showcasing robust demand for its products.
- Bristol-Myers Squibb's Stock Increase: The pharmaceutical giant's stock gained 2% after posting fourth-quarter adjusted earnings of $1.26 per share and revenues of $12.5 billion, both exceeding analyst expectations, highlighting its competitive strength and growth potential in the market.
See More
